Get the Stockscreener App
5.53
1.47%
0.08
Glucotrack Inc stock is traded at $5.53, with a volume of 16,819.
It is up +1.47% in the last 24 hours and down -23.19% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$5.45
Open:
$5.3
24h Volume:
16,819
Relative Volume:
0.01
Market Cap:
$2.64M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-2.6976
EPS:
-2.05
Net Cash Flow:
$-8.25M
1W Performance:
-4.16%
1M Performance:
-23.19%
6M Performance:
+1,379%
1Y Performance:
-88.90%
1-Day Range:
$5.30
$5.6399
1-Week Range:
$5.11
$5.9169
52-Week Range:
$0.0927
$62.60
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
5.53 | 3.25M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Glucotrack Inc Stock (GCTK) Latest News
Is It Too Late to Sell GlucoTrack Inc.Market Trend Review & Weekly Top Stock Performers List - classian.co.kr
Glucotrack, Inc. Reports Progress and Financial Results - TipRanks
Top chart patterns to watch in GlucoTrack Inc.Quarterly Portfolio Summary & Weekly High Potential Alerts - Newser
What MACD signals say about GlucoTrack Inc.Market Trend Summary & Fast Gain Swing Alerts - Newser
What Fibonacci levels say about GlucoTrack Inc. rebound2025 Technical Overview & Stock Portfolio Risk Management - Newser
Can trapped investors hope for a rebound in GlucoTrack Inc.Weekly Stock Summary & Consistent Growth Equity Picks - Newser
Will GlucoTrack Inc. continue its uptrendTrade Performance Summary & Precise Swing Trade Alerts - Newser
Long term hold vs stop loss in GlucoTrack Inc.IPO Watch & Weekly Watchlist for Hot Stocks - Newser
Best data tools to analyze GlucoTrack Inc. stock2025 Market Outlook & Risk Managed Investment Signals - Newser
What high frequency data says about GlucoTrack Inc.Dollar Strength & AI Based Buy and Sell Signals - Newser
How GlucoTrack Inc. stock performs during market volatilityJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
What makes GlucoTrack Inc. stock price move sharplyWeekly Gains Summary & Trade Opportunity Analysis - sundaytimes.kr
How much upside does GlucoTrack Inc. have2025 Investor Takeaways & Precise Entry and Exit Recommendations - thegnnews.com
Heatmap analysis for GlucoTrack Inc. and competitorsJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Is GlucoTrack Inc. forming a bullish divergencePrice Action & Reliable Entry Point Alerts - mustnews.co.kr
GlucoTrack Inc. Stages Intraday Comeback — Trend ChangeJuly 2025 Institutional & AI Forecast for Swing Trade Picks - sundaytimes.kr
GlucoTrack Reports Q2 Results: Mixed Performance, Strong Capital Structure, and Positive Data Presentations. - AInvest
GlucoTrack's High-Stakes Gamble: Can a 3-Year Implantable CGM Justify the Burn? - AInvest
GlucoTrack Reports Q2 Results and Corporate Highlights - TipRanks
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Revolutionary Implantable Diabetes Monitor Achieves 99% Data Capture Rate in Human Trial - Stock Titan
Volatility clustering patterns for GlucoTrack Inc.July 2025 Setups & Free Weekly Chart Analysis and Trade Guides - Newser
How ATCH stock performs during market volatilityBreakout Picks for 2x Returns - thegnnews.com
Why GlucoTrack Inc. stock attracts strong analyst attentionMega Return Stock Alerts - newsyoung.net
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - 富途牛牛
GlucoTrack GCTK 2025Q2 Earnings Preview Upside Potential on Innovative Product Launch - AInvest
GlucoTrack Appoints Dr. Hirsh as Medical Director to Enhance CBGM Development - AInvest
GlucoTrack Appoints Dr. Hirsh as Medical Director - TipRanks
Cardiac electrophysiologist Hirsh joins Glucotrack’s clinical team By Investing.com - Investing.com South Africa
Cardiac electrophysiologist Hirsh joins Glucotrack’s clinical team - Investing.com
Glucotrack Appoints Dr. David Hirsh as Medical Director for Cardiology Advisory Team. - AInvest
Revolutionary 3-Year Implantable Diabetes Monitor Advances as Glucotrack Strengthens Medical Leadership - Stock Titan
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology - MarketScreener
What are the latest earnings results for GlucoTrack Inc.Maximize your gains with expert trading tips - Jammu Links News
What are the technical indicators suggesting about GlucoTrack Inc.Invest smarter with actionable stock recommendations - Jammu Links News
GlucoTrack Inc. Stock Analysis and ForecastAchieve rapid portfolio appreciation today - Jammu Links News
What are GlucoTrack Inc. company’s key revenue driversAchieve unparalleled market performance - Jammu Links News
What is the dividend policy of GlucoTrack Inc. stockFree Wealth Management Insights - Jammu Links News
Contrasting GlucoTrack (NASDAQ:GCTK) & BioLife Solutions (NASDAQ:BLFS) - Defense World
What is the risk reward ratio of investing in GlucoTrack Inc. stockMaximize gains with expert analysis - Jammu Links News
How many analysts rate GlucoTrack Inc. as a “Buy”Phenomenal wealth increase - Jammu Links News
What are analysts’ price targets for GlucoTrack Inc. in the next 12 monthsInvest smarter with expert stock picks - Jammu Links News
How does GlucoTrack Inc. compare to its industry peersExceptional financial outcomes - Jammu Links News
Is GlucoTrack Inc. a good long term investmentBuild wealth faster with consistent investment plans - Jammu Links News
How strong is GlucoTrack Inc. company’s balance sheetConsistent high-performance stocks - Jammu Links News
Is GlucoTrack Inc. a growth stock or a value stockPowerful market insights - Jammu Links News
How does GlucoTrack Inc. generate profit in a changing economyInvest confidently with market-leading analysis - Jammu Links News
Does GlucoTrack Inc. stock perform well during market downturnsAccelerated financial growth - Jammu Links News
Is it the right time to buy GlucoTrack Inc. stockGet exclusive access to expert stock recommendations - Jammu Links News
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):